Indaptus Therapeutics
INDP
INDP
25 hedge funds and large institutions have $72.2M invested in Indaptus Therapeutics in 2018 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
87% less call options, than puts
Call options by funds: $11K | Put options by funds: $87K
Holders
25
Holding in Top 10
1
Calls
$11K
Puts
$87K
Top Buyers
| 1 | +$2.67M | |
| 2 | +$1.77M | |
| 3 | +$1.22M | |
| 4 |
DMK
David M. Knott
|
+$1.21M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
+$903K |
Top Sellers
| 1 | -$13M | |
| 2 | -$3.4M | |
| 3 | -$200K | |
| 4 |
Renaissance Technologies
New York
|
-$200K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$133K |